Diagnostic disclosure in Alzheimer’s Disease: A review
نویسندگان
چکیده
Although growing, the literature on research into attitudes of general and specialized physicians towards disclosing the diagnosis of dementia and Alzheimer's disease (AD), or the current practice on AD disclosure, remains limited. Moreover, information is also scarce on what caregivers, or indeed patients themselves, wish to know with regard to their diagnosis. The goal of the present article was to present a review of the current available literature on the topic of truth telling in dementia, especially in AD. The studies discussed in this review were mainly conducted in Europe, particularly in the United Kingdom, as well as the United States. Disclosure of AD diagnosis is not a common practice among physicians. In the clinical context, the discussion on diagnosis disclosure can be valuable for improving the care of AD patients and their families.
منابع مشابه
Comparing the Diagnostic Value of Four Dementia Tests in the Amnestic and Healthy Elderly
Objective: This study aimed to compare the diagnostic value of 4 questionnaires for the diagnosis of neurocognitive disorders (NCDs) in the elderly. Methodology: In this project, people older than 60 years who lived in Tehran were investigated. A total of 99 literate persons were enrolled in the study, and 4 questionnaires of functional assessment staging tool (FAST), abbreviated mental test s...
متن کاملDiagnosis of prodromal Alzheimer's disease: do you really want to know?
1. Porteri C, Galluzzi S, Geroldi C, Frisoni GB. Diagnosis disclosure of prodromal Alzheimer disease – ethical analysis of two cases. Can J Neurol Sci. 2010; 37: 67-75. 2. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer’s disease: revisiting of the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6: 734-46. 3. Gauthi...
متن کاملBiomarker-based diagnosis of mild cognitive impairment due to Alzheimer’s disease: how and what to tell. A kickstart to an ethical discussion
New criteria for the diagnosis of Alzheimer's disease (AD) based on biomarker results have recently been developed and are currently undergoing extensive validation. The next few years may represent a time window where the diagnostic validity of biomarkers will be studied in highly specialized research settings. Biomarkers results will be used to direct clinical diagnosis and, whenever appropri...
متن کاملAPOE Genotype Disclosure for Risk of Alzheimer’s Disease: The REVEAL Study
Background: APOE genotype provides information on risk of developing Alzheimer’s disease (AD), but disclosure is discouraged. We examined the impact of APOE disclosure in a prospective randomized controlled trial: the Risk Evaluation and Education for Alzheimer’s Disease (REVEAL) Study. Methods: We randomly assigned 162 asymptomatic adult children of AD patients to Genotype Disclosure (GD) or G...
متن کاملAssessing the Effects of Alzheimer’s disease on EEG Signals Using the Entropy Measure: a Meta-Analysis
Introduction and Aims: Alzheimer’s disease is the most prevalent neurodegenerative disorder and a type of dementia. 80% of dementia in older adults is because of Alzheimer’s disease. According to multiple research articles, Alzheimer's has several changes in EEG signals such as slowing of rhythms, reduction in complexity and reduction in functional associations, and disordered functional commun...
متن کامل